Skip to content
GHIAA Logo Small
Envelope
Linkedin-in
Twitter
  • Home
  • Our Work
    • GHIAA
    • MAPGuide
  • About
    • About GHIAA
    • Team
  • News
  • Resources
    • Useful Links
    • COVID19
  • Contact
  • search
Menu
  • Home
  • Our Work
    • GHIAA
    • MAPGuide
  • About
    • About GHIAA
    • Team
  • News
  • Resources
    • Useful Links
    • COVID19
  • Contact
  • search
 
search
Tweets by GHIAAteam

GHIAA Supporters

Special thanks to our supporters at Duke Law School Community Enterprise Clinic

If you are interested in providing funding or an in-kind contribution to support GHIAA’s work, please contact us using the form below.  

Global Health Innovation Alliance Accelerator is a 501(c)(3) non-profit recognized by the IRS.

Contact Us

Get In Touch

info@ghiaa.org

Tel: 919-419-0300
919-906-4818
Fax: 919-419-8833

Attn: Executive Director
GHIAA
PO Box 14713
Research Triangle Park, NC 27709, USA

Browse

Our Work
MAPGuide
About GHIAA
Team
News
Useful Links
COVID19

Contact Us

Get In Touch

info@ghiaa.org

Tel: 919-419-0300
919-906-4818
Fax: 919-419-8833

Attn: Executive Director
GHIAA
PO Box 14713
Research Triangle Park, NC 27709, USA

Browse

GHIAA
MAPGuide
About GHIAA
Team
News
Links
COVID19

 

Twitter
Linkedin-in

info@ghiaa.org

Privacy Policy

  • Privacy Policy
  • Join
Menu
  • Privacy Policy
  • Join

© 2021 Global Health Innovation Alliance Accelerator. All Rights Reserved

Close Menu

Sign Up to Our Newsletter

Receive updates about GHIAA’s latest tools, resources and news.

I consent to receiving email updates from GHIAA and have read and agree to the Privacy Policy and Terms of Service..

Select Technology

  • Any Technologies
  • Device
  • Diagnostic
  • Drug
  • Vaccine

Select Partner Type

  • Any Partner types
  • Academic institution
  • Biotechnology company
  • Contract research organization
  • Funder
  • General Industry
  • Government
  • Multilateral organization
  • Multinational pharmaceutical company
  • Other nonprofit
  • Pharmaceutical manufacturer
  • Product development partnership
  • Vaccine manufacturer

Select Development Stage

  • Any Develoment stages
  • Discovery/Concept
  • Preclinical
  • Early clinical (through Phase 2)
  • Late clinical (Phase 3)
  • Commercialization
  • Field Testing

Select Issue or Sub-issues

  • Access to medicines
    • All Access to medicines
    • Equitable access
    • Funder step-in rights
    • Outbreak preparedness
    • Pandemic Products
    • Policy considerations
    • Affordable or reasonable pricing
    • Public health licenses
    • Supply/Purchase of Products
  • Annexes
    • All Annexes
    • Commercialization strategy
    • Global access plans
    • Regulatory strategy
  • Business model
    • All Business model
    • Benefit/revenue sharing
    • Risk sharing
    • Royalties & payments
  • Consortium structure & management
    • Consortium structure & management
  • Information sharing & data safety
    • All Information sharing & data safety
    • Confidentiality
    • Data management
    • Exceptions and limitations to the confidentiality obligations
    • Information sharing
    • Material transfer
    • Technology transfer
  • IP ownership & licensing
    • All IP ownership & licensing
    • Access to results
    • Exceptions or limitations to the IP ownership rules
    • Exploitation of results
    • Ownership of background IP
    • Ownership of results
    • Protection of results
    • Sublicenses
    • Use of background IP
  • Liability
    • All Liability
    • Indemnity / indemnification
    • Insurance
    • Limitation of liability/damage
    • Warranties
  • Open sciences & open data
    • All Open sciences & open data
    • Data & material sharing
    • Open data
    • Open sciences
    • Publication
  • Other
    • All Other
    • Conflict of Interest
    • Dispute resolution
    • Reporting
    • Survival
  • Term & termination
    • All Term & termination
    • Effect of termination
    • Term of agreement
    • Termination & withdrawal